COLL vs PHM · P/E 17, rev $181.9M vs P/E 7.7, rev $17.95B
Collegium Pharmaceutical Inc (COLL) versus PulteGroup Inc (PHM) — a side-by-side from cached financials, not a winner call.
Collegium Pharmaceutical Inc (COLL) is a drug manufacturers - specialty & generic company listed on NASDAQ.
PulteGroup Inc (PHM) is a residential construction company listed on US.
Latest reported COLL revenue for 2024-12-31 was $181.9M. Net income was $69.2M. Revenue was up 14.2% from 2024-09-30 to 2024-12-31. COLL currently screens at market cap $1.12B and trailing P/E 16.8.
Latest reported PHM revenue for 2024-12-31 was $17.95B. Net income was $3.08B. Revenue was up 11.7% from 2023-12-31 to 2024-12-31. PHM currently screens at market cap $21.92B and trailing P/E 7.7.
COLL currently screens at market cap $1.12B and trailing P/E 16.8. PHM currently screens at market cap $21.92B and trailing P/E 7.7.
Not investment advice. Open the COLL and PHM stock pages for the full models.
Not investment advice.